Chemical Component Summary

Name5-BROMOTHIENYLDEOXYURIDINE
Identifiers5-(5-bromothiophen-2-yl)-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione
FormulaC13 H13 Br N2 O5 S
Molecular Weight389.22
TypeNON-POLYMER
Isomeric SMILESOC[C@H]1O[C@H](C[C@@H]1O)n1cc(-c2ccc(Br)s2)c(=O)[nH]c1=O
InChIInChI=1S/C13H13BrN2O5S/c14-10-2-1-9(22-10)6-4-16(13(20)15-12(6)19)11-3-7(18)8(5-17)21-11/h1-2,4,7-8,11,17-18H,3,5H2,(H,15,19,20)/t7-,8+,11+/m0/s1
InChIKeyIGUZFFOBAZCVRK-VAOFZXAKSA-N

Chemical Details

Formal Charge0
Atom Count35
Chiral Atom Count3
Chiral AtomsC1', C3', C4'
Bond Count37
Aromatic Bond Count5
Leaving Atomsn/a

Drug Info: DrugBank

DrugBank IDDB03804 Different stereochemistry
Name5-Bromothienyldeoxyuridine
Groupsexperimental

Drug Targets

NameSequence SearchPharmacological ActionActions
Thymidine kinaseMASYPCHQHASAFDQAARSRGHNNRRTALRPRRQQEATEVRPEQKMPTLL...unknown
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682